Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
unclassifiableSWon-SCACCTGTGCCTGTTAAACCA20502321323194R-20215.9South Korea
B.1.1.389SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-20215.9South Korea
CH.1.1.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-20212.4China
EG.9NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20210.5Japan
A.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-20208.4South Korea
B.1.516SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-20207.4Japan
N.3SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-20207.4Japan
GJ.4SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-20207.4Japan
XBB.2.8SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-20207.4Japan
B.1.1.425SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-20207.4Japan
BN.1.3.4SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-20207.4Japan
CH.1.1.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-20199.5Germany
BE.7NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20194.8US
BE.8NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20194.8US
BE.12NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20194.8US
BE.11NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20194.8US
BE.6NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20194.8US
BE.9NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20194.8US
BE.13NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20194.8US
BA.5.3.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-20194.8US
AY.21 (Delta)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-20194.6China
B.1.438.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.252NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.438.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.438.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.182NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.1.218NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.438NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.587NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.588NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.160.20ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20179.2China
AY.21 (Delta)ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.160.20ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.160.19ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.160.12ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
AT.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.619.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
P.1.12.1 (Gamma)ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.160.22ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
AZ.2.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.260ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.456ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.160.16ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
AY.4.16 (Delta)ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
BA.1.22ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.177.70ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.177.42ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.1.428ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.1.374ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
AY.63 (Delta)ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used